scholarly journals Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells

2018 ◽  
Vol 71 (1) ◽  
pp. 149-163 ◽  
Author(s):  
Kamila Maliszewska-Olejniczak ◽  
Klaudia K. Brodaczewska ◽  
Zofia F. Bielecka ◽  
Wojciech Solarek ◽  
Anna Kornakiewicz ◽  
...  
2018 ◽  
Vol 14 (3) ◽  
pp. 385-397 ◽  
Author(s):  
Anna Kornakiewicz ◽  
Anna M. Czarnecka ◽  
Mohammed I. Khan ◽  
Paweł Krasowski ◽  
Anna V. Kotrys ◽  
...  

2017 ◽  
Vol 56 (11) ◽  
pp. 2499-2511 ◽  
Author(s):  
Xiao-Fei Zhang ◽  
De-sheng Weng ◽  
Ke Pan ◽  
Zi-Qi Zhou ◽  
Qiu-zhong Pan ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-12 ◽  
Author(s):  
Anna Julie Peired ◽  
Alessandro Sisti ◽  
Paola Romagnani

Renal cell carcinoma (RCC) is a major neoplasm with high incidence in western countries. Tumors are heterogeneous and are composed of differentiated cancer cells, stromal cells, and cancer stem cells (CSCs). CSCs possess two main properties: self-renewal and proliferation. Additionally, they can generate new tumors once transplanted into immunodeficient mice. Several approaches have been described to identify them, through the expression of cell markers, functional assays, or a combination of both. As CSCs are involved in the resistance mechanisms to radio- and chemotherapies, several new strategies have been proposed to directly target CSCs in RCC. One approach drives CSCs to differentiate into cancer cells sensitive to conventional treatments, while the other proposes to eradicate them selectively. A series of innovative therapies aiming at eliminating CSCs have been designed to treat other types of cancer and have not been experimented with on RCC yet, but they reveal themselves to be promising. In conclusion, CSCs are an important player in carcinogenesis and represent a valid target for therapy in RCC patients.


2011 ◽  
Vol 71 (15) ◽  
pp. 5346-5356 ◽  
Author(s):  
Cristina Grange ◽  
Marta Tapparo ◽  
Federica Collino ◽  
Loriana Vitillo ◽  
Christian Damasco ◽  
...  

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii450-iii450
Author(s):  
Grazia Serino ◽  
Fabio Sallustio ◽  
Vanessa Galleggiante ◽  
Monica Rutigliano ◽  
Claudia Curci ◽  
...  

2020 ◽  
Vol 26 (17) ◽  
pp. 1964-1978 ◽  
Author(s):  
Pengchao Fang ◽  
Liuting Zhou ◽  
Lee Y. Lim ◽  
Hualin Fu ◽  
Zhi-xiang Yuan ◽  
...  

Renal cell carcinoma (RCC) is an intractable genitourinary malignancy that accounts for approximately 4% of adult malignancies. Currently, there is no approved targeted therapy for RCC that has yielded durable remissions, and they remain palliative in intent. Emerging evidence has indicated that renal tumorigenesis and RCC treatment-resistance may originate from renal cancer stem cells (CSCs) with tumor-initiating capacity (CSC hypothesis). A better understanding of the mechanism underlying renal CSCs will help to dissect RCC heterogeneity and drug treatment efficiency, to promote more personalized and targeted therapies. In this review, we summarized the stem cell characteristics of renal CSCs. We outlined the targeting strategies and challenges associated with developing therapies that target renal CSCs angiogenesis, immunosuppression, signaling pathways, surface biomarkers, microRNAs and nanomedicine. In conclusion, CSCs are an important role in renal carcinogenesis and represent a valid target for treatment of RCC patients.


2014 ◽  
Vol 141 (6) ◽  
pp. 1013-1024 ◽  
Author(s):  
Lin Wang ◽  
Paul Park ◽  
Frank La Marca ◽  
Khoi D. Than ◽  
Chia-Ying Lin

2011 ◽  
Vol 103 (24) ◽  
pp. 1884-1898 ◽  
Author(s):  
Sandy Azzi ◽  
Stefania Bruno ◽  
Julien Giron-Michel ◽  
Denis Clay ◽  
Aurore Devocelle ◽  
...  

2021 ◽  
pp. 002215542110351
Author(s):  
Anamarija Habič ◽  
Metka Novak ◽  
Bernarda Majc ◽  
Tamara Lah Turnšek ◽  
Barbara Breznik

Proteolytic activity is perturbed in tumors and their microenvironment, and proteases also affect cancer stem cells (CSCs). CSCs are the therapy-resistant subpopulation of cancer cells with tumor-initiating capacity that reside in specialized tumor microenvironment niches. In this review, we briefly summarize the significance of proteases in regulating CSC activities with a focus on brain tumor glioblastoma. A plethora of proteases and their inhibitors participate in CSC invasiveness and affect intercellular interactions, enhancing CSC immune, irradiation, and chemotherapy resilience. Apart from their role in degrading the extracellular matrix enabling CSC migration in and out of their niches, we review the ability of proteases to modulate CSC properties, which prevents their elimination. When designing protease-oriented therapies, the multifaceted roles of proteases should be thoroughly investigated.


Sign in / Sign up

Export Citation Format

Share Document